Rewinding the ticker tape. Jim Roppel, founder of the Roppel Report, joins the “Investing with IBD” podcast to share his analysis of the panic bottom, strategies for removing hedges and the signals he’s seeing of a quiet bull case building in the market. Learn about the drug development potential of Eli Lilly (LLY), the bull case in Nvidia (NVDA) and why Cava (CAVA) is in a class of its own.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Investing With IBD